Skip to main content
Caplight Logo









Nurami Medical

Nurami Medical

Private
HaifaHealthcare & Life Scienceshttps://www.nurami-medical.com/

Last Round

Series C

Mar 4, 2025

Total Funding Raised

$46.2M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Nurami Medical is a biotechnology company that develops and manufactures nanofiber-based products for soft tissue repair.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

surgical sealantdural patchcerebrospinal fluid leakageCSF leakageneurosurgical devicesbiodegradable implantssurgical graftelectrospun nanofibersdural repairbiomaterialssoft tissue repairmedtechsurgical consumablesimplantable devices

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nurami Medical Comparables

Compare Nurami Medical with similar companies based on industry and business-model similarity.

Nurami Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pramand
88%
Neomend
86%
Medprin Regenerative Medical Technologies Co. Ltd.
84%

Nurami Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CMar 4, 2025
GrantJul 16, 2024
GrantJul 2, 2024
Series BNov 2, 2020
VC RoundJul 16, 2019
Series A
Jul 1, 2018

Key People

Founding team and executive leadership

Nora Nseir

Co-Founder and CEO

Founding Team

Mira Rosenzweig

Chief Financial Officer

Executive Team

Amir Bahar

Board Member, Chief Clinical Officer

Executive Team

Nurami Medical Investors

Notable investors and investment history

Nurami Medical investors
InvestorRounds
European Innovation Council FundGrant
huMannity MedtecVC Round, Seed
Israel Innovation AuthorityGrant, VC Round
Next Generation Technology (NGT3VC)Grant
GlenRock IsraelSeries B
Almeda VenturesSeries B
Iron NationSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors grew 141% MoM, reaching 450.

  • Jul 16, 2024

    Secured $3M from European Innovation Council Fund and Israel Innovation Authority.

Nurami Medical Filings

Explore SEC and related filing metadata, where available.

Nurami Medical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Nurami Medical's valuation, stock price, and market status.

Is Nurami Medical a public or private company?

Nurami Medical is a private company.

What is the current stock price of Nurami Medical?

Nurami Medical is a private company with no public stock price. No recent secondary market data is available.

How much is Nurami Medical worth (valuation)?

Valuation information for Nurami Medical is not publicly available.

Can I buy Nurami Medical stock?

Nurami Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Nurami Medical's last funding round?

Nurami Medical's most recent funding round was Series C on March 4, 2025.

Who are the main investors in Nurami Medical?

Key investors in Nurami Medical include huMannity Medtec, Almeda Ventures.

Will Nurami Medical IPO soon?

No public IPO plans have been announced for Nurami Medical.

How can I track Nurami Medical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nurami Medical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHaifa
Employee Range29
Year Founded2014
Last FundingMar 4, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?